For the year ending 2025-12-31, CRH had $388M increase in cash & cash equivalents over the period. $2,912M in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | 3,790 | 3,521 | 3,072 |
| Depreciation, depletion and amortization | 2,156 | 1,798 | 1,633 |
| Loss on impairments | 40 | 161 | 357 |
| Share-based compensation | 143 | 125 | 123 |
| Gains on disposals from discontinued operations, businesses and long-lived assets, net | - | 431 | 66 |
| Gains on disposals from businesses and long-lived assets, net | 247 | - | - |
| Deferred tax expense (benefit) | 167 | 180 | -64 |
| (income) loss from equity method investments | 26 | -108 | -17 |
| Pension and other postretirement benefits net periodic benefit cost | 21 | 34 | 31 |
| Non-cash operating lease costs | 292 | 262 | 293 |
| Other items, net | -3 | -14 | -68 |
| Accounts receivable, net | -121 | 122 | 164 |
| Inventories | 161 | 224 | 60 |
| Accounts payable | -158 | 48 | 144 |
| Operating lease liabilities | -310 | -287 | -276 |
| Other assets | 210 | 69 | -25 |
| Other liabilities | 45 | -86 | -72 |
| Pension and other postretirement benefits contributions | -41 | -43 | -44 |
| Net cash provided by operating activities | 5,625 | 4,989 | 5,017 |
| Purchases of property, plant and equipment, and intangibles | 2,713 | 2,578 | 1,817 |
| Cash consideration | 3,916 | 4,953 | - |
| Less cash and cash equivalents acquired | 60 | 53 | - |
| Acquisitions, net of cash acquired | 3,856 | 4,900 | 640 |
| Proceeds from divestitures | 139 | 1,001 | 6 |
| Proceeds from disposal of long-lived assets | 315 | 272 | 104 |
| Dividends received from equity method investments | 50 | 44 | 44 |
| Settlements of derivatives | 81 | 9 | 1 |
| Deferred divestiture consideration received | 42 | 83 | - |
| Other investing activities, net | -59 | 204 | 87 |
| Net cash used in investing activities | -6,045 | -6,291 | -2,391 |
| Proceeds from debt issuances | 10,479 | 4,001 | 3,163 |
| Payments on debt | 7,612 | 1,859 | 1,462 |
| Settlements of derivatives | -121 | 36 | -7 |
| Payments of finance lease obligations | 131 | 57 | 26 |
| Deferred and contingent acquisition consideration paid | 31 | 21 | 22 |
| Dividends paid | 996 | 1,706 | 940 |
| Distributions to noncontrolling and redeemable noncontrolling interests | 34 | 53 | 35 |
| Transactions involving noncontrolling interests | 28 | 19 | 2 |
| Repurchases of common stock | 1,181 | 1,482 | 3,067 |
| Proceeds from exercise of stock options | - | 8 | 4 |
| Amounts related to employee share plans | 47 | - | - |
| Net cash provided by (used in) financing activities | 596 | -1,186 | -2,380 |
| Effect of exchange rate changes on cash and cash equivalents, including restricted cash | 212 | -143 | 208 |
| Increase (decrease) in cash and cash equivalents, including restricted cash | 388 | -2,631 | 454 |
| Cash and cash equivalents at beginning of period | 3,759 | 6,390 | 5,936 |
| Cash and cash equivalents at end of period | 4,147 | 3,759 | 6,390 |
CRH PUBLIC LTD CO (CRH)
CRH PUBLIC LTD CO (CRH)